Science-driven partner for pharma and biotech that validates drug candidates early using a BSL3 laboratory, unique platform and multiomics technologies. Delivers custom services — mouse model creation and humanization, high-content immunoprofiling, primary T-cell editing and 3Rs-focused in vitro/in vivo assays — to identify, validate and prioritize targets in immuno-oncology, inflammatory, autoimmune and infectious diseases.